Aptose Biosciences Investor Relations Material
Latest events
Q4 2023
Aptose Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Aptose Biosciences Inc
Access all reports
Aptose Biosciences Inc., a biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. In addition, the company is developing product candidates using Allogeneic Natural Killer Cell Pharmacological Chimeric Receptors (NK-PRRs) to treat cancer, with NK-PRR strategies designed to target specific tumor antigens. The company's mission is to deliver therapies that fit the precise characteristics of individual patients, by providing tailor-made, autologous treatments that harness a patient’s own immune system cells to fight disease.
Key slides for Aptose Biosciences Inc
Study Update
Aptose Biosciences Inc
Study Update
Aptose Biosciences Inc
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States